Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women
- 1 February 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9050) , 458-461
- https://doi.org/10.1016/s0140-6736(96)07365-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal WomenJAMA, 1996
- Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal WomenJAMA, 1995
- Combined Estrogen and Progesterone Use and Endometrial CancerEpidemiology, 1993
- Estrogens, Progesterone, and Endometrial CancerEpidemiology, 1993
- Progestagen supplementation of exogenous oestrogens and risk of endometrial cancerThe Lancet, 1991
- Benefits and risks of menopausal estrogen and/or progestin hormone usePreventive Medicine, 1988
- Reliability of Women's Histories of Climacteric Oestrogen Treatment Assessed by Prescription FormsInternational Journal of Epidemiology, 1987
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal womenBMJ, 1978
- Sampling Methods for Random Digit DialingJournal of the American Statistical Association, 1978